【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Predictive Genetic Testing & Consumer/Wellness Genomics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Rise in number of novel partnership models
3.1.1.2 Introduction of fragmented point-solutions across the genomics value chain
3.1.1.3 Exponentially decreasing costs for genetic sequencing
3.1.1.4 Introduction of technological advancements in cloud computing and data integration
3.1.2 Market Restraint Analysis
3.1.2.1 Absence of well-defined regulatory framework and low adoption rate
3.1.2.2 Ethical concerns pertaining to implementation
3.2 Penetration & Growth Prospect Mapping for Applications, 2015
3.3 Predictive genetic testing & consumer/wellness genomics-Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Type Estimates & Trend Analysis
4.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Types Movement Analysis
4.2 Predictive Testing
4.2.1 Global predictive testing market, 2013 – 2025 (USD Million)
4.2.2 Genetic susceptibility test
4.2.2.1 Global genetic susceptibility test market, 2013 – 2025 (USD Million)
4.2.3 Predictive diagnostics
4.2.3.1 Global predictive diagnostics test market, 2013 – 2025 (USD Million)
4.2.4 Population screening programs
4.2.4.1 Global population screening programs market, 2013 – 2025 (USD Million)
4.3 Consumer Genomics
4.3.1 Global consumer genomics market, 2013 – 2025 (USD Million)
4.4 Wellness Genetics
4.4.1 Global wellness genetics market, 2013 – 2025 (USD Million)
4.4.2 Nutria Genetics
4.4.2.1 Global nutria genetics market, 2013 – 2025 (USD Million)
4.4.3 Skin & Metabolism Genetics
4.4.3.1 Global skin & metabolism genetics market, 2013 – 2025 (USD Million)
4.4.4 Others
4.4.4.1 Global others market, 2013 – 2025 (USD Million)
Chapter 5 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Estimates & Trend Analysis
5.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Movement Analysis
5.2 Breast & Ovarian Cancer Screening
5.2.1 Global breast & ovarian cancer screening market, 2013 – 2025 (USD Million)
5.3 Cardiovascular Screening
5.3.1 Global cardiovascular screening market, 2013 – 2025 (USD Million)
5.4 Diabetic Screening & Monitoring
5.4.1 Global diabetic screening & monitoring market, 2013 – 2025 (USD Million)
5.5 Colon Cancer Screening
5.5.1 Global colon cancer screening market, 2013 – 2025 (USD Million)
5.6 Parkinsonism / Alzheimer’s disease
5.6.1 Global Parkinsonism / Alzheimer’s disease market, 2013 – 2025 (USD Million)
5.7 Urologic Screening/ Prostate Cancer Screening
5.7.1 Global urologic screening/ prostate cancer screening market, 2013 – 2025 (USD Million)
5.8 Orthopedic & Musculoskeletal Screening
5.8.1 Global orthopedic & musculoskeletal screening market, 2013 – 2025 (USD Million)
5.9 Other Cancer Screening
5.9.1 Global other cancer screening market, 2013 – 2025 (USD Million)
5.10 Other Diseases Screening
5.10.2 Global other diseases screening market, 2013 – 2025 (USD Million)
Chapter 6 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Regional Estimates & Trend Analysis, by Test Type & Application
6.1 Predictive Genetic Testing & Consumer/Wellness Genomics Market Share By Region, 2015 & 2025
6.2 North America
6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.2 U.S.
6.2.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.2.3 Canada
6.2.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3 Europe
6.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.2 Germany
6.3.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.3.3 UK
6.3.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4 Asia Pacific
6.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.2 Japan
6.4.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.3 China
6.4.3.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.4 Australia
6.4.4.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.5 India
6.4.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.4.6 Singapore
6.4.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5 Latin America
6.5.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.5.2 Brazil
6.5.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6 MEA
6.6.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
6.6.2 South Africa
6.6.2.1 Predictive genetic testing & consumer/wellness genomics market, 2013 – 2025 (USD Million)
Chapter 7 Competitive Landscape
7.1 Strategy framework
7.2 Market participation categorization
7.2.1 Key Initiatives
7.3 Company Profiles
7.3.1 F. Hoffmann-La Roche Ltd
7.3.1.1 Company overview
7.3.1.1.1 454 Life Sciences (Roche Diagnostics Corporation)
7.3.1.2 Financial performance
7.3.1.3 Product benchmarking
7.3.1.4 Strategic initiatives
7.3.2 Abbott (Abbott Diagnostics)
7.3.2.1 Company overview
7.3.2.2 Financial performance
7.3.2.3 Product benchmarking
7.3.2.4 Strategic initiatives
7.3.3 Thermo Fisher Scientific, Inc.
7.3.3.1 Company overview
7.3.3.1.1 Affymetrix, Inc.
7.3.3.1.2 Applied Biosystems
7.3.3.2 Financial performance
7.3.3.2.1 Financial performance (Affymetrix)
7.3.3.3 Product benchmarking
7.3.3.4 Strategic initiatives
7.3.4 Agilent Technologies
7.3.4.1 Company overview
7.3.4.2 Financial performance
7.3.4.3 Product benchmarking
7.3.4.4 Strategic initiatives
7.3.5 BGI
7.3.5.1 Company overview
7.3.5.1.1 Complete Genomics Incorporated
7.3.5.2 Financial performance
7.3.5.3 Product benchmarking
7.3.5.4 Strategic initiatives
7.3.6 Bio-Rad Laboratories, Inc.
7.3.6.1 Company overview
7.3.6.1.1 GnuBIO, Inc.
7.3.6.2 Financial performance
7.3.6.3 Product benchmarking
7.3.6.4 Strategic initiatives
7.3.7 Illumina, Inc.
7.3.7.1 Company overview
7.3.7.2 Financial performance
7.3.7.3 Product benchmarking
7.3.7.4 Strategic initiatives
7.3.8 QIAGEN
7.3.8.1 Company overview
7.3.8.2 Financial performance
7.3.8.3 Product benchmarking
7.3.8.4 Strategic initiatives
7.3.9 Alere
7.3.9.1 Company overview
7.3.9.2 Financial performance
7.3.9.3 Product benchmarking
7.3.9.4 Strategic initiatives
7.3.10 Myriad Genetics, Inc.
7.3.10.1 Company overview
7.3.10.2 Financial performance
7.3.10.3 Product benchmarking
7.3.10.4 Strategic initiatives
7.3.11 Siemens Healthineers
7.3.11.1 Company overview
7.3.11.2 Financial performance
7.3.11.3 Product benchmarking
7.3.11.4 Strategic initiatives
7.3.12 Pathway Genomics
7.3.12.1 Company overview
7.3.12.2 Financial performance
7.3.12.3 Product benchmarking
7.3.12.4 Strategic initiatives
7.3.13 Cooper Surgical, Inc.
7.3.13.1 Company overview
7.3.13.1.1 Genesis Genetics
7.3.13.1.2 Reprogenetics
7.3.13.1.3 Financial performance
7.3.13.1.4 Financial performance
7.3.13.2 Product benchmarking
7.3.13.3 Strategic initiatives
7.3.14 Ambry Genetics Corporation
7.3.14.1 Company overview
7.3.14.2 Financial performance
7.3.14.3 Product benchmarking
7.3.14.4 Strategic initiatives
7.3.15 23andMe, Inc.
7.3.15.1 Company overview
7.3.15.2 Financial performance
7.3.15.3 Product benchmarking
7.3.15.4 Strategic initiatives
7.3.16 Danaher
7.3.16.1 Company overview
7.3.16.1.1 Beckman Coulter, Inc.
7.3.16.2 Financial performance
7.3.16.3 Product benchmarking
7.3.16.4 Strategic initiatives
7.3.17 Cepheid
7.3.17.1 Company overview
7.3.17.2 Financial performance
7.3.17.3 Product benchmarking
7.3.17.4 Strategic initiatives
7.3.18 Hologic, Inc. (Gen-Probe Incorporated)
7.3.18.1 Company overview
7.3.18.2 Financial performance
7.3.18.3 Product benchmarking
7.3.18.4 Strategic initiatives
7.3.19 ARUP Laboratories
7.3.19.1 Company overview
7.3.19.2 Financial performance
7.3.19.3 Product benchmarking
7.3.19.4 Strategic initiatives
7.3.20 GUARDANT HEALTH, INC
7.3.20.1 Company overview
7.3.20.2 Financial performance
7.3.20.3 Product benchmarking
7.3.20.4 Strategic initiatives
7.3.21 Advanced Genomic Solutions (AGS) Ltd
7.3.21.1 Company overview
7.3.21.2 Financial performance
7.3.21.3 Product benchmarking
7.3.21.4 Strategic initiatives
7.3.22 EasyDNA
7.3.22.1 Company overview
7.3.22.2 Financial performance
7.3.22.3 Product benchmarking
7.3.22.4 Strategic initiatives
7.3.23 Color Genomics, Inc.
7.3.23.1 Company overview
7.3.23.2 Financial performance
7.3.23.3 Product benchmarking
7.3.23.4 Strategic initiatives
7.3.24 Counsyl, Inc.
7.3.24.1 Company overview
7.3.24.2 Financial performance
7.3.24.3 Product benchmarking
7.3.24.4 Strategic initiatives
7.3.25 Gene by Gene
7.3.25.1 Company overview
7.3.25.2 Financial performance
7.3.25.3 Product benchmarking
7.3.26 Mapmygenome
7.3.26.1 Company overview
7.3.26.2 Financial performance
7.3.26.3 Product benchmarking
7.3.26.4 Strategic initiatives
7.3.27 Interleukin Genetics Inc.
7.3.27.1 Company overview
7.3.27.2 Financial performance
7.3.27.3 Product benchmarking
7.3.27.4 Strategic initiatives
7.3.28 Laboratory Corporation of America Holdings (LabCorp)
7.3.28.1 Company overview
7.3.28.2 Financial performance
7.3.28.3 Product benchmarking
7.3.28.4 Strategic initiatives
7.3.29 Quest Diagnostics Incorporated
7.3.29.1 Company overview
7.3.29.1.1 Sonora Quest Laboratories
7.3.29.2 Financial performance
7.3.29.2.1 Financial performance
7.3.29.3 Product benchmarking
7.3.29.4 Strategic initiatives
7.3.30 Xcode
7.3.30.1 Company overview
7.3.30.2 Financial performance
7.3.30.3 Product benchmarking
7.3.30.4 Strategic initiatives
7.3.31 Amgen, Inc.
7.3.31.1 Company overview
7.3.31.1.1 deCODE genetics
7.3.31.2 Financial performance (Amgen, Inc.)
7.3.31.3 Product benchmarking
【レポート販売概要】
■ タイトル：予測遺伝子検査と消費者/ウェルネスゲノミクスの世界市場分析：用途別（がん、糖尿病のスクリーニング、パーキンソン病、循環器、整形外科･筋骨格系、ヌートリア遺伝学、皮膚･代謝遺伝学）、動向分析、2013-2025■ 英文：Predictive Genetic Testing And Consumer/Wellness Genomics Market By Application (Cancer, Diabetic Screening, Parkinsonism, Cardiovascular, Orthopedic & Musculoskeletal, Nutria Genetics, Skin & Metabolism Genetics), And Trend Analysis From 2013 To 2025
■ 発行日：2017年1月27日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707698
■ 調査対象地域：グローバル
- セルビアの通信、IPネットワーク、デジタルメディア市場Executive summary Telecom revenue showing continuing effects of a slow economy Following an economically and politically turbulent period during the 1990s, Serbia started the first decade of the new millennium with strong GDP growth until the economic crisis of 2008 restricted both growth and investment. GDP growth soon recovered but it has been stymied by the poor performance of Serbia’s neighbou …
- 熱伝導性材料の世界市場：ポリマー材料、フェイズチェンジ材、金属材料About TIM TIM is used to support heat sinks in removing heat from heat sources in various equipment. It is generally used in the form of a secondary thermally conducting material to replace the thermally insulating air between the two surfaces. Along with helping in the efficient transfer of heat, TIM also acts as an adhesive and strengthens the mechanical link between the surfaces. Polymer-based …
- ダイボンダー装置の世界市場2017-2021ABSTRACTAbout Die Bonder Equipment Die bonder equipment are a type of semiconductor packaging and assembly equipment in which wafers are cut into dies, and the functional dies are separated from the defective ones, which are already marked before this step. bonder equipment are a type of semiconductor packaging and assembly equipment in which wafers are cut into dies, and the functional dies are s …
- 脊髄性筋萎縮症(Spinal Muscular Atrophy (SMA))の治療薬パイプライン動向（2015年上半期版）Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2015’, provides an overview of the Spinal Muscular Atrophy (SMA)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Spinal Muscular Atrophy (SMA), complete with comparative analysis at various stages, t …
- 質量分析法（MS）の世界市場予測（～2022年）：種類、用途、地域別分析The global mass spectrometry market is expected to reach USD 5.27 Billion by 2022 from USD 3.68 Billion in 2017, at a CAGR of 7.4%. The growth of this market is majorly driven by technological advancements in mass spectrometry, government initiatives for pollution control and environmental testing, increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety an …
- 外陰部腟カンジダ症(Vulvovaginal Candidiasis)：世界の治験レビュー2014年下半期版Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2014" provides data on the Vulvovaginal Candidiasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Vulvovaginal Candidiasis. It includes an overview of the trial num …
- マイクロ‐グリッド（小規模発電網）の世界市場予測（～2022年）The microgrid market was valued at USD 16.58 Billion in 2015 and is expected to reach USD 38.99 Billion by 2022, at a CAGR of 12.45% during the forecast period. Many countries are focusing on innovations, and expansions are being carried out through rural electrification projects, which would help increase the demand for microgrid systems in the coming years. The microgrid market has been segmente …
- 世界の風力発電産業トレンド分析：Analyzing Trends in the Global Wind Power IndustryAs demand on finite petroleum reserves and the price of the fuels derived from them continues to rise, renewable forms of energy are becoming more cost-effective and profitable. In the forefront of this renewable revolution is harnessing the sustainable power of wind. Today it is one of the most positive developments created by the present storm of uncertainty unleashed as a result of escalating o …
- 防弾ガラスの世界市場2016-2020：銀行セキュリティ、現金輸送車、ATMブース、ディスプレイケースAbout Bulletproof Glass Bulletproof glass, also known as ballistic or bullet-resistant glass, is a composite of thermoplastic and glass-laminated layers. The combined substance is used to resist or absorb the impact of bullets or similar ammunition. Bulletproof glass is prepared by inserting a layer of thermoplastic in between the laminated glasses, and different layers are stacked together. Depen …
- 海底制御装置の世界市場：海底制御モジュール、アンビリカル・ターミネーション・アセンブリ、主制御システム、センサー等This report estimates the subsea control systems market, in terms of market size. The market has been segmented into types (underwater & topside), applications (production, processing, & others), components (subsea control module, umbilical termination assembly, umbilical, master control systems, sensors, & others) and regions (North America, Europe, Asia-Pacific, the Middle East & Africa, and Sou …
- カオリンの世界市場動向2014/2015The report presents a thorough study of kaolin, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing kaolin worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: kaolin production in the country, major manufacturers …
- マイクロフルイディクス（微少流体技術）の世界市場：材料（ポリマー、ガラス、シリコン）、用途、地域別分析Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to rising demand for point-of-care (POC) testing, increasing use of miniaturized microfluidic chips to achieve faster testing and improved portability, and increased prevalence of age-related and lifestyle diseases and disorders. The global microfluidics market is expected to grow at a significant CAGR …
- 自動車用ホイールアライメントシステムの世界市場2019-2023Global Automotive Wheel Alignment System Market: About this market Technavio’s automotive wheel alignment system market analysis considers sales from CCD wheel alignment system,3D wheel alignment system, and DIY wheel alignment system. Our analysis also considers the sales of automotive wheel alignment system in APAC, Europe, North America, South America, and MEA. In 2018, the CCD wheel alignment …
- Atrasentan (Microvascular Complications of Diabetes)：市場予測と分析（～2022）Atrasentan (Microvascular Complications of Diabetes) - Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the spars …
- 遺伝子組み換え（GM）種子の世界市場2016-2020About Genetic Modification Genetic modification (GM), also called genetic engineering (GE), is a technology where new traits are introduced into an organism by directly manipulating its genetic makeup. For instance, Deoxyribonucleic acid (DNA), is introduced or manipulated through intervention at the molecular level using biotechnology. In the process of this technology, scientists manipulate the …
